Federation des caisses Desjardins du Quebec’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-200
Closed -$2.96K – 2523
2022
Q3
$2.96K Hold
200
– – ﹤0.01% 2190
2022
Q2
$5.48K Sell
200
-80
-29% -$2.37K ﹤0.01% 2101
2022
Q1
$10.6K Hold
280
– – ﹤0.01% 2007
2021
Q4
$17.4K Hold
280
– – ﹤0.01% 1879
2021
Q3
$24K Hold
280
– – ﹤0.01% 1799
2021
Q2
$17.3K Hold
280
– – ﹤0.01% 1905
2021
Q1
$13.7K Sell
280
-75
-21% -$3.62K ﹤0.01% 1917
2020
Q4
$11.1K Sell
355
-250
-41% -$6.12K ﹤0.01% 1889
2020
Q3
$12.6K Buy
+605
New +$10.4K ﹤0.01% 1623

Other funds holding OPRX

Federation des caisses Desjardins du Quebec's OPRX Position: Q4 2022 in Review

Federation des caisses Desjardins du Quebec sold out of OptimizeRx (OPRX) in Q4 2022, closing a stake of 200 shares — an estimated $2.96K sold.

Federation des caisses Desjardins du Quebec first reported a position in OPRX in Q3 2020 and held it in 9 quarters. The position peaked at $24K in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q4 2022.

  • Federation des caisses Desjardins du Quebec reported no remaining OptimizeRx position as of Q4 2022 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 200 OptimizeRx shares in Q4 2022, an estimated $2.96K.
  • Federation des caisses Desjardins du Quebec first reported a position in OptimizeRx in Q3 2020 and held it in 9 quarters.
  • Federation des caisses Desjardins du Quebec's OptimizeRx position peaked at $24K in Q3 2021.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2022.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2022, filed 15 Aug 2024.